Chudova Darya 4

What Happened Darya Chudova, Chief Technology Officer of Guardant Health (GH), was granted 23,856 restricted stock units (RSUs) on March 11, 2026. The RSUs were granted at $0.00 (no cash paid) and are recorded as a derivative award; there was no immediate sale or purchase of shares.

Key Details

• Transaction date: March 11, 2026; Form 4 filed March 13, 2026. No late filing indication in the report.
• Grant: 23,856 RSUs; reported price $0.00 (derivative award), reported value $0 at grant.
• Vesting: 33% of the award vests April 1, 2027; the remaining 67% vests in equal quarterly installments over the two years thereafter (three-year total vesting period). (Footnote F1)
• Footnote F2: Not applicable for Restricted Stock Units.
• Shares owned after transaction: Not specified in the filing.

Context This was a time-based equity award (RSUs), not an open-market purchase or sale. RSUs typically convert to actual shares only as they vest and may be subject to company withholding for taxes; such future vesting/withholding events would be reported separately when they occur. Awards are routine compensation for executives and do not, by themselves, indicate buying or selling sentiment.